ERGO is part of the EURION Cluster Group of eight research projects from the Call ‘New Testing and Screening Methods to Identify Endocrine Disrupting Chemicals’. Funded by the EU Horizon 2020 Research and Innovation Programme, this is the largest public funding of this type of research in Europe. The Cluster Group will optimise synergies and avoid overlaps between the projects.

Each project is focussing on a different aspect of new testing and screening methods identifying EDCs. However, the projects will share expertise to maximize EURION’s impact.